BridgeBio have substantially advanced the course of an novel solution for cardiac amyloidosis, employing Attruby. Preliminary patient information suggests significant benefits for individuals suffering by a severe illness. The effort underscores researchers’ focus to treating unmet patient needs in this heart field. Attruby: BridgeBio's… Read More